This brief compiles the key public details for three high-interest upcoming IPOs — Canara Robeco Asset Management Company, Rubicon Research, and Canara HSBC Life Insurance — and explains why grey market premiums (GMPs) are moving. The facts below were read from the screenshot you provided and verified against market reports before publication.

Core data points (price bands, reported GMPs and timing) are used to form an investor-facing view; GMPs are unofficial indicators and should be treated as directional only.

Canara Robeco AMC — price band ₹253–₹266; reported GMP ~₹35 per share, indicating potential double-digit listing gains versus the upper band.

Rubicon Research — price band reported around ₹461–₹485; grey market commentary has shown elevated premiums (circa ~₹80 in the unlisted/grey chatter).

Canara HSBC Life Insurance — price band ₹100–₹106; reported GMPs in the range that imply mid-to-high single-digit to low-double-digit premium on listing if sustained.

For quick trade/derivatives ideas related to short-term listing momentum, see our Nifty Option Tips—remember these are intraday directional plays.

Grey Market Premiums are a market sentiment gauge — they show what unlisted participants are willing to pay ahead of a formal listing. A ₹30–₹80 GMP on an IPO with a price band in the low hundreds typically points to expectation of a double-digit listing jump at open.

Important limits of GMPs: they are not regulated, can be volatile, differ by dealer/data-vendor, and often move on rumours, anchor allocations, and institutional demand cues.

⚠️ GMPs are unofficial. Use them only as one input among valuation, peer metrics and the DRHP (company fundamentals).

Canara Robeco AMC

The AMC business is valued for AUM growth, fee margin resilience and distribution strength. With a priced band at ₹253–₹266 and GMP near ₹35, the market is pricing in strong listing interest — partly because AMCs have seen robust secondary market liquidity and investor appetite for asset-management franchises.

Key near-term watch: anchor allocations, reported subscription splits and any last-minute changes in the offer structure.

Rubicon Research

Rubicon’s offering is being watched for its revenue mix and margin profile; a price band around ₹461–₹485 together with reported grey market interest (circa ₹80) suggests strong speculative demand. For growth-oriented IPOs, GMPs often reflect hot investor sentiment more than long-term valuation.

If you’re focused on fundamentals, compare Rubicon’s P/E (on listed peer set) and margin durability rather than trading solely on GMP.

Here is another derivatives reference which is Bank Nifty Intraday for short-term hedged plays around listing events — use tight risk controls.

Canara HSBC Life Insurance

Insurance IPOs trade on franchise strength, persistency and solvency metrics. With the price band near ₹100–₹106 and GMPs suggesting a ~10–15% implied listing uplift, investors should weigh embedded value metrics and solvency ratios alongside short-term market momentum.

Watch for regulatory disclosures and the insurer’s FY guidance — these move institutional demand, which in turn influences listing behaviour.

Gulshan Khera, CFP®, who is a SEBI Regd Investment Adviser, notes that GMPs are a short-term sentiment signal — useful to traders and options players — but are not a substitute for DRHP-led fundamental checks. If GMPs are high but subscription data (retail/QIB bids) are weak, listing momentum can disappoint.

Practical guidance: if you plan to subscribe, consider waiting until the final day to review subscription velocity; for secondary trading, prefer strategies that cap downside (protective options, tight stop-losses).

• GMPs for these three IPOs signal strong near-term interest — they may translate into listing gains but are unofficial and volatile.

• If you’re a subscriber: validate fundamentals (DRHP), compare with listed peers, and watch final subscription volumes; consider subscribing on the last day if GMP is the only reason to act.

• If you’re a trader: use hedged option strategies; if you’re a long-term investor, prioritise valuation, solvency (for insurance) and AUM/fee trends (for AMC).

Related queries

Why are GMPs for Rubicon Research rising ahead of its IPO?

What solvency metrics should investors check for Canara HSBC Life?